Natriuretic peptide vs. clinical information for diagnosing heart dysfunction
Author Information
Author(s): Koschack Janka, Scherer Martin, Lüers Claus, Kochen Michael M, Wetzel Dirk, Kleta Sibylle, Pouwels Claudia, Wachter Rolf, Herrmann-Lingen Christoph, Pieske Burkert, Binder Lutz
Primary Institution: Georg-August-University Göttingen, Germany
Hypothesis
Is natriuretic peptide testing a useful and cost-effective diagnostic tool in primary care for left ventricular systolic dysfunction?
Conclusion
Clinical information is at least as effective as NT-proBNP testing in ruling out left ventricular systolic dysfunction in at-risk patients.
Supporting Evidence
- 23 out of 542 patients showed left ventricular systolic dysfunction.
- Both NT-proBNP and the clinical risk score had excellent diagnostic power.
- The AUC for NT-proBNP was 0.83 and for the clinical risk score was 0.85.
- The clinical risk score had a higher specificity than NT-proBNP.
Takeaway
Doctors can use simple patient information to check for heart problems instead of relying only on blood tests.
Methodology
The study compared NT-proBNP levels and a clinical risk score in 542 patients with cardiovascular risk factors to assess their effectiveness in diagnosing left ventricular systolic dysfunction.
Potential Biases
The study may not have accounted for all relevant clinical factors, potentially affecting the validity of the risk score.
Limitations
The sample size was too small to derive age and gender adjusted cut-off values, and the study may be biased due to the selection of independent variables.
Participant Demographics
Patients included had at least one cardiovascular risk factor, with a mean age of 63 years.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI, 0.75 to 0.92
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website